Journals / Gülhane Tıp Dergisi / 2022 / Cilt: 64 - Sayı: 2

Use of high flow nasal cannula as a modality of acute respiratory failure due to COVID-19

Pages
128–135
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is also important to clarify its contraindications and factors associated with HFNC failure.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Oxygen (O2 ) therapy is the first-line therapy for acute respiratory distress with hypoxemia due to Coronavirus disease-2019 (COVID-19).
📊
Key Findings & Data:High-flow nasal cannula (HFNC) therapy represents one of the O2 therapy alternative modalities.
💡
Conclusion & Impact:It is also important to clarify its contraindications and factors associated with HFNC failure.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Oxygen (O2 ) therapy is the first-line therapy for acute respiratory distress with hypoxemia due to Coronavirus disease-2019 (COVID-19). High-flow nasal cannula (HFNC) therapy represents one of the O2 therapy alternative modalities. HFNC is a supportive O2 therapy device using a specially designed HFNC warmed and moisturizer, resulting in a stable flow rate. The physiological mechanisms of HFNC make its efficacy better than other O2 therapy applications. Management of COVID-19 focuses on preventing disease worsening, and HFNC can optimize the outcome of therapy. Further studies are necessary to evaluate the benefits of HFNC in hypoxemia management. It is also important to clarify its contraindications and factors associated with HFNC failure.

🔖

Cite This Article

ISWANTO, I., MARFIANI, E., DEWİ, K. P., AMIN, M., DEWİ, I. P. (2022). Use of high flow nasal cannula as a modality of acute respiratory failure due to COVID-19. Gülhane Tıp Dergisi, Cilt: 64 - Sayı: 2, 128–135. https://ajindex.com/articles/526742

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. WHO. Report of the WHO - China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020. Available from: https://www. who.int/docs/default-source/coronaviruse/who-china-jointmission-on-covid-19---final-report-1100hr-28feb2020-11marupdate.pdf?sfvrsn=1a13fda0_2&download=true 2. PDPI. Pneumonia COVID-19 Diagnosis & Penatalaksanaan di Indonesia. 2020
  2. CDC. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12 March 16, 2020. Available from: https://www.cdc.gov/mmwr/ volumes/69/wr/mm6912e2.htm. 4. Roca O, Caralt B, Messika J, et al. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. Am J Respir Crit Care Med. 2019
  3. Wettstein RB, Shelledy DC, Peters JI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care. 2005
  4. Segovia B, Velasco D, Jaureguizar OA, Díaz Lobato S. Combination Therapy in Patients with Acute Respiratory Failure: High-Flow Nasal Cannula and Non-Invasive Mechanical ventilation. Arch Bronconeumol (Engl Ed). 2019
  5. Sharma S, Danckers M, Sanghavi D, Chakraborty RK. High flow nasal cannula. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2021. 8. De Jong A, Calvet L, Lemiale V, et al. The challenge of avoiding intubation in immunocompromised patients with acute respiratory failure. Expert Rev Respir Med. 2018
  6. Mauri T, Galazzi A, Binda F, et al. Impact of flow and temperature on patient comfort during respiratory support by high-flow nasal cannula. Crit Care. 2018
  7. Nishimura M. High-flow nasal cannula oxygen therapy in adults. J Intensive Care. 2015
  8. Renda T, Corrado A, Iskandar G, Pelaia G, Abdalla K, Navalesi P. High-flow nasal oxygen therapy in intensive care and anaesthesia. Br J Anaesth. 2018
  9. Zhang J, Lin L, Pan K, Zhou J, Huang X. High-flow nasal cannula therapy for adult patients. J Int Med Res. 2016
  10. Thille AW, Muller G, Gacouin A, et al. Effect of postextubation high-flow nasal oxygen with noninvasive ventilation vs highflow nasal oxygen alone on reintubation among patients at high risk of extubation failure: a randomized clinical trial. JAMA. 2019
  11. Adhikari P, Bhattarai S, Gupta A, et al. Physiological Effects of High-Flow Nasal Cannula Therapy and Its Use in Acute Cardiogenic Pulmonary Edema. Cureus. 2021
  12. e13372. 15. Parke RL, Bloch A, McGuinness SP